References
- DavsonHHistory of the blood-brain barrier conceptNeuweltEAImplications of the Blood-Brain Barrier and Its Manipulation1New YorkPlenum Press19892752
- BanksWAPhysiology and pathology of the blood-brain barrier: implications for microbial pathogenesis, drug delivery and neurodegenerative disordersJ Neurovirol19995653855510602396
- HawkinsBTDavisTPThe blood-brain barrier/neurovascular unit in health and diseasePharmacol Rev200557217318515914466
- PardridgeWMThe blood-brain barrier: bottleneck in brain drug developmentNeuroRx20052131415717053
- BallabhPBraunANedergaardMThe blood-brain barrier: an overview: structure, regulation, and clinical implicationsNeurobiol Dis200416111315207256
- PardridgeWMBlood-brain barrier deliveryDrug Discov Today2007121–2546117198973
- AbbottNJRönnbäckLHanssonEAstrocyte-endothelial interactions at the blood-brain barrierNat Rev Neurosci200671415316371949
- KongSDLeeJRamachandranSMagnetic targeting of nanoparticles across the intact blood-brain barrierJ Control Release20121641495723063548
- HamiltonRDFossAJLeachLEstablishment of a human in vitro model of the outer blood-retinal barrierJ Anat2007211670771617922819
- NeuweltEABauerBFahlkeCEngaging neuroscience to advance translational research in brain barrier biologyNat Rev Neurosci201112316918221331083
- ShubayevVIPisanicTRJinSMagnetic nanoparticles for theragnosticsAdv Drug Deliv Rev200961646747719389434
- WahajuddinMAroraSSuperparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriersInt J Nanomedicine201273445347122848170
- DaveSRGaoXMonodisperse magnetic nanoparticles for biodetection, imaging, and drug delivery: a versatile and evolving technologyWiley Interdiscip Rev Nanomed Nanobiotechnol20091658360920049819
- KodamaRHMagnetic nanoparticlesJ Magn Magn Mater19992001–3359372
- PlankCZelphatiOMykhaylykOMagnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospectsAdv Drug Deliv Rev20116314–151300133321893135
- IannettiGDWiseRGBOLD functional MRI in disease and pharmacological studies: room for improvement?Magn Reson Imaging200725697898817499469
- IadecolaCNeurovascular regulation in the normal brain and in Alzheimer’s diseaseNat Rev Neurosci20045534736015100718
- OberdörsterGSharpZAtudoreiVTranslocation of inhaled ultrafine particles to the brainInhal Toxicol2004166–743744515204759
- KleinmanMTAraujoJANelAInhaled ultrafine particulate matter affects CNS inflammatory processes and may act via MAP kinase signaling pathwaysToxicol Lett2008178212713018420360
- LogothetisNKPaulsJAugathMNeurophysiological investigation of the basis of the fMRI signalNature2001412684315015711449264
- ShiDSunLLMiGControlling ferrofluid permeability across the blood-brain barrier modelNanotechnology201425707510124457539
- NayarSSinhaAPramanickAKinventorsA biomimetic process for the synthesis of aqueous ferrofluids for biomedical applicationsIndian patent number0672DEL20103222010
- BhattacharyaSSheikhLTiwariVProtein-polymer functionalized aqueous ferrofluids showing high T2 relaxivityJ Biomed Nanotechnol201410581181924734534
- HoffDSheikhLBhattacharyaSNayarSWebsterTJComparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood-brain barrierInt J Nanomedicine2013870371023426527
- BennettJBasivireddyJKollarABlood-brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAEJ Neuroimmunol20102291–218019120832870
- BrownRCMorrisAPO’NeilRGTight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cellsBrain Res200711301173017169347